Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.

Latest Post

December 17, 2019

The FDA released four final guidances pertaining to the 510(K) program

The FDA’s Center for Devices and Radiological Health (CDRH) released four final guidance documents on Thursday, Sept. 12, which provides the FDA’s current thinking on the Special 510(K) program, the Abbreviated 510(K) program, how to format Traditional and Abbreviated 510(K)s and the new Refuse to Accept policy for 510(K).
Di Wu

Di Wu

Sr. Specialist, Regulatory Affairs


Search the Blog





  • Previous Posts
    Blue West logo with Diamond

    April 16, 2014

    New FDA Guidance Issued for Annual Reportable Changes

    Steve LoCastro

    Steve LoCastro

    Director, Regulatory Affairs

    Blue West logo with Diamond

    October 16, 2013

    Seeking Subvisible Particles

    West Pharma

    Whitney Winters

    Director, Sales, Emerging Biologics